Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: Does it affect diagnosis or prognosis?

Talhat Azemi; Mridula Rai; Purvi Parwani; Sarkis Baghdasarian; Fawad Kazi; Alan W. Ahlberg; Giselle Cyr; Deborah Katten; David O'Sullivan; Daniel Fram; Gary V. Heller

doi:10.1007/s12350-011-9457-x

Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: Does it affect diagnosis or prognosis?

Talhat Azemi
, Mridula Rai
, Purvi Parwani
, Sarkis Baghdasarian
, Fawad Kazi
, Alan W. Ahlberg
, Giselle Cyr
, Deborah Katten
, David O'Sullivan
, Daniel Fram
, Gary V. Heller

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	84-91
Number of pages	8
Journal	Journal of Nuclear Cardiology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1007/s12350-011-9457-x
State	Published - Feb 2012
Externally published	Yes

ASJC Scopus Subject Areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Keywords

Coronary artery disease
Diagnosis and prognosis application
Outcomes research
SPECT
Vasodilator stress
Prognosis
Humans
Middle Aged
Male
Incidence
Exercise Test
Electrocardiography/statistics & numerical data
Female
Risk Assessment/methods
Myocardial Perfusion Imaging/statistics & numerical data
Connecticut/epidemiology
Adenosine
Risk Factors
Dipyridamole
Survival Rate
Tomography, Emission-Computed, Single-Photon/statistics & numerical data
Coronary Artery Disease/diagnosis
Vasodilator Agents
Survival Analysis
Aged

Access to Document

10.1007/s12350-011-9457-x

OpenUrl availability

Full text

Cite this

@article{5dc51105e6554b3e894bca3edc967937,

title = "Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: Does it affect diagnosis or prognosis?",

keywords = "Coronary artery disease, Diagnosis and prognosis application, Outcomes research, SPECT, Vasodilator stress, Prognosis, Humans, Middle Aged, Male, Incidence, Exercise Test, Electrocardiography/statistics \& numerical data, Female, Risk Assessment/methods, Myocardial Perfusion Imaging/statistics \& numerical data, Connecticut/epidemiology, Adenosine, Risk Factors, Dipyridamole, Survival Rate, Tomography, Emission-Computed, Single-Photon/statistics \& numerical data, Coronary Artery Disease/diagnosis, Vasodilator Agents, Survival Analysis, Aged",

author = "Talhat Azemi and Mridula Rai and Purvi Parwani and Sarkis Baghdasarian and Fawad Kazi and Ahlberg, \{Alan W.\} and Giselle Cyr and Deborah Katten and David O'Sullivan and Daniel Fram and Heller, \{Gary V.\}",

note = "Funding Information: From the Nuclear Cardiology Laboratory, Henry Low Heart Center, Division of Cardiology,a Hartford Hospital, Hartford CT; University of Connecticut School of Medicine,b Farmington, CT; and Uni-versity of California, San Francisco School of Medicine,c San Francisco, CA. Supported by a grant from the Department of Research Administration, Hartford Hospital, Hartford, CT, USA. Received for publication Jan 7, 2011; final revision accepted Aug 31, 2011. Reprint requests: Talhat Azemi, MD, Nuclear Cardiology Laboratory, Henry Low Heart Center, Division of Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102; [email protected]. 1071-3581/\$34.00 Copyright {\textcopyright} 2011 American Society of Nuclear Cardiology. doi:10.1007/s12350-011-9457-x",

year = "2012",

month = feb,

doi = "10.1007/s12350-011-9457-x",

language = "English",

volume = "19",

pages = "84--91",

journal = "Journal of Nuclear Cardiology",

issn = "1071-3581",

number = "1",

}

TY - JOUR

T1 - Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging

T2 - Does it affect diagnosis or prognosis?

AU - Azemi, Talhat

AU - Rai, Mridula

AU - Parwani, Purvi

AU - Baghdasarian, Sarkis

AU - Kazi, Fawad

AU - Ahlberg, Alan W.

AU - Cyr, Giselle

AU - Katten, Deborah

AU - O'Sullivan, David

AU - Fram, Daniel

AU - Heller, Gary V.

N1 - Funding Information: From the Nuclear Cardiology Laboratory, Henry Low Heart Center, Division of Cardiology,a Hartford Hospital, Hartford CT; University of Connecticut School of Medicine,b Farmington, CT; and Uni-versity of California, San Francisco School of Medicine,c San Francisco, CA. Supported by a grant from the Department of Research Administration, Hartford Hospital, Hartford, CT, USA. Received for publication Jan 7, 2011; final revision accepted Aug 31, 2011. Reprint requests: Talhat Azemi, MD, Nuclear Cardiology Laboratory, Henry Low Heart Center, Division of Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102; [email protected]. 1071-3581/$34.00 Copyright © 2011 American Society of Nuclear Cardiology. doi:10.1007/s12350-011-9457-x

PY - 2012/2

Y1 - 2012/2

KW - Coronary artery disease

KW - Diagnosis and prognosis application

KW - Outcomes research

KW - SPECT

KW - Vasodilator stress

KW - Prognosis

KW - Humans

KW - Middle Aged

KW - Male

KW - Incidence

KW - Exercise Test

KW - Electrocardiography/statistics & numerical data

KW - Female

KW - Risk Assessment/methods

KW - Myocardial Perfusion Imaging/statistics & numerical data

KW - Connecticut/epidemiology

KW - Adenosine

KW - Risk Factors

KW - Dipyridamole

KW - Survival Rate

KW - Tomography, Emission-Computed, Single-Photon/statistics & numerical data

KW - Coronary Artery Disease/diagnosis

KW - Vasodilator Agents

KW - Survival Analysis

KW - Aged

UR - https://www.scopus.com/pages/publications/84861498481

UR - https://www.scopus.com/pages/publications/84861498481#tab=citedBy

U2 - 10.1007/s12350-011-9457-x

DO - 10.1007/s12350-011-9457-x

M3 - Article

C2 - 21947978

AN - SCOPUS:84861498481

SN - 1071-3581

VL - 19

SP - 84

EP - 91

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

IS - 1

ER -

Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: Does it affect diagnosis or prognosis?

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this